Maturometer 2024

Omnichannel transformation: Where's the pharma industry at? 

Each year we survey colleagues and customers from the life science industry to collate their perspectives on the state of digital transformation in their own organization. From industry satisfaction to digital marketing budgets, Cx, AI, …the resulting Maturometer report aims to summarize pharma’s progress towards omnichannel maturity – as viewed by the people who work in it. Simply tap the button below and complete a short form in order to access this unique insight into the state of digital maturity in life sciences in 2024!
 
Please note: The Maturometer survey was issued by Across Health earlier this year; we have since rebranded to Precision AQ. 

Get unmissable insights on a range of topics, including:

• Pharma digital budgets and internal satisfaction
• Most common bottlenecks for digital
• Global-to-local (in)efficiency 
• Adoption of AI in customer engagement efforts
• Digital knowledge/skill levels

To give you an idea of what this year’s Maturometer offers, we are pleased to provide you with two highlights below. 

Want to dive into the full report immediately?  

                                                                            Download Maturometer Report

In addition, you can watch the highlights of Maturometer™ 2024 being discussed by our experts in our recent webinar, which is now available on-demand. 

MLR ISSUES AND ROI CONCERNS TOP THE LIST OF COMMON BOTTLENECKS FOR DIGITAL

Looking at those factors thought to be getting in the way of digital progress among EU biopharma organizations, MLR (Medical, Legal & Regulatory) issues and uncertainties around ROI continue to be an important obstruction for digital success -  and the gap between these has closed significantly since last year’s survey. Meanwhile, lack of internal knowledge, technologies and strategy consistently fill out the top 5 bottlenecks, presenting opportunities for pharma to make use of better strategic planning, tracking and upskilling.

Are current investments failing to show results…or is there rather a lack of confidence/knowledge regarding the appropriate metrics for digital initiatives?

                                                                          Download Maturometer Report

THERE IS SIGNIFICANT INTEREST IN AI, BUT ITS EFFECTIVE IMPLEMENTATION REMAINS CHALLENGING

When asked "What's the current level of adoption of Al in your company's customer engagement efforts?" only 11% of European biopharma respondents reported no interest at all in AI in their organization. In fact, the data indicate a strong inclination to incorporate AI in customer engagement efforts, with over a third having progressed beyond the “interested” stage to pilots and beyond. 

Are they finding it challenging to turn their AI ambitions into reality because the basics - particularly data quality and organization - are not yet in place?

                                                                           Download Maturometer Report